Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirofiban after IV thrombolysis in acute ischemic stroke
NCT06134622Phase 3Completed
- Sponsor
- The First Affiliated Hospital of University of Science and Technology of China
- Start
- Mar 2024
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tirofiban in ischemic stroke, sponsored by The First Affiliated Hospital of University of Science and Technology of China. Started Mar 2024; status: completed.
02
Drugs
tirofiban
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06134622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06134622.